Fedro Pharmaceutical Labs products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Peshawar · Pakistan
Peshawar-based pharmaceutical manufacturer represented in DRAP GMP inspection records.
Fedro Pharmaceutical Labs products in Pakistan
Fedro Pharmaceutical Labs Pvt Ltd has 76 medicine presentations registered in Pakistan under 34 brands, covering 31 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Fedraxil (Amoxicillin), Cephdro (Cephradine), Fedmalt (Iron, Iron + Folic acid) and Fedragyl (Metronidazole (Benzoate), Metronidazole). 76 products have an official DRAP price on MedInfoBase. See all 34 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Fedro Pharmaceutical Labs (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 149, Industrial Estate, Hayatabad, Peshawar, Khyber Pakhtunkhwa, Pakistan
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 50%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Fedro Pharmaceutical Labs Pvt Ltd is priced against the market
67 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Ayanomox | Moxifloxacin | 400 mg | Tablet | 5s | 112779 | PKR 627.14 | PKR 125.43/tablet | 🔒 Pharma Pro |
| Ciprofed | Ciprofloxacin | 250 mg | Tablet | 10s | 059490 | PKR 235.39 | PKR 23.54/tablet | 🔒 Pharma Pro |
| Ciprofed | Ciprofloxacin | 500 mg | Tablet | 10s | 059491 | PKR 379.01 | PKR 37.90/tablet | 🔒 Pharma Pro |
| Leefed | Levofloxacin | 500 mg | Tablet | 10s | 051147 | PKR 404.07 | PKR 40.41/tablet | 🔒 Pharma Pro |
| Leefed | Levofloxacin | 250 mg | Tablet | 10s | 059492 | PKR 235.39 | PKR 23.54/tablet | 🔒 Pharma Pro |
All 34 Fedro Pharmaceutical Labs brands in Pakistan
- Ayanomox Moxifloxacin · 400 mg tablet
- Bendaset Albendazole · 200 mg tablet
- Brufed Ibuprofen · 100 mg/5 mL suspension, 400 mg tablet
- Carbanem Meropenem · 1 g injection, 500 mg injection
- Cardfed Plus 5 Amlodipine · 160 mg tablet
- Cardfed Plus 5/80 Amlodipine · 5 mg tablet
- Cefilxin Cephalexin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- Cefilxin Caps Cephalexin · 250 mg capsule, 500 mg capsule
- Cefilxin DS Cephalexin · 250 mg/5 mL suspension
- Cephdro Cephradine · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Ciprofed Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Clarifed Clarithromycin · 250 mg tablet, 500 mg tablet
- Cordfed Amlodipine · 5 mg tablet
- Deprefed Fluoxetine · 20 mg capsule
- Deprefed-O 12 Olanzapine · 25 mg capsule
- Deprefed-O 6 Olanzapine · 25 mg capsule
- Di-Mether Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
- Fedazole Omeprazole · 20 mg capsule, 40 mg injection
- Fedmalt Iron, Iron + Folic acid · 100 mg tablet, 100 mg + 0.35 mg tablet, 50 mg/5 mL syrup
- Fedragyl Metronidazole (Benzoate), Metronidazole · 200 mg/5 mL suspension, 400 mg tablet, 400 mg + 500 mg tablet
- Fedragyl DF Metronidazole + Diloxanide furoate · 200 mg + 250 mg suspension
- Fedramol Paracetamol · 120 mg/5 mL suspension
- Fedraxil Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Fedro-D3 Cholecalciferol · 200,000 IU/mL injection
- Fedroprid Risperidone · 3 mg tablet
- Fedroquine Amodiaquine · 200 mg tablet
- Fedroxime Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- Fedxamic Tranexamic acid · 250 mg capsule, 500 mg capsule
- Fedzobac Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Femazole Clotrimazole · 500 mg tablet
- Fluco-Z Fluconazole · 150 mg capsule
- Leefed Levofloxacin · 250 mg tablet, 500 mg tablet
- Vanpin Simvastatin · 20 mg tablet
- Zefed Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
Fedro Pharmaceutical Labs: common questions
How many products does Fedro Pharmaceutical Labs have in Pakistan?
Fedro Pharmaceutical Labs Pvt Ltd has 76 registered medicine presentations in Pakistan, sold under 34 brands and covering 31 generic medicines.
What are the main brands of Fedro Pharmaceutical Labs?
By number of registered strengths and packs, its largest brands are Fedraxil (Amoxicillin), Cephdro (Cephradine), Fedmalt (Iron, Iron + Folic acid), Fedragyl (Metronidazole (Benzoate), Metronidazole) and Fedroxime (Cefixime). This is not a sales ranking.
Which therapy areas does Fedro Pharmaceutical Labs cover?
The most products are in Anti-infectives (51), CNS & mental health (8), Vitamins, minerals & nutrition (6), Cardiovascular (4) and Pain & musculoskeletal (3).
Where can I see Fedro Pharmaceutical Labs medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.